Dr. Reddy’s Laboratories has launched ‘Obeda’, an injectable semaglutide therapy for diabetes and weight management in India.
Dr Reddy's Laboratories has announced the launch of its injectable semaglutide under the brand name Obeda, marking an important step in expanding access to GLP-1 receptor agonist-based therapy for the ...
SINGAPORE, SINGAPORE, SINGAPORE, March 20, 2026 /EINPresswire.com/ -- As we navigate the sophisticated landscape of ...
Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
A drug that cost over Rs 10,000 a month is now available for as little as Rs 220 a shot. Multiple companies have entered the ...
Financial data pours into accounting systems from all sorts of sources—banks, payment processors, spreadsheets, third-party apps—you name it. Each one has its o ...
MiniMax M2.7 fully tested as an agentic AI model, showing 30% autonomous self-improvement after 100+ self-training rounds.
Right then, choosing an enterprise integration platform in 2026 might sound like a big deal, and honestly, it is. Your ...
Model selection, infrastructure sizing, vertical fine-tuning and MCP server integration. All explained without the fluff. Why Run AI on Your Own Infrastructure? Let’s be honest: over the past two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results